{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp06_four_proposal_generalization60_20260803","cell_id":"catalytic_pathway_enablement__nanotechnology","arm":"COMPLETE_PROPOSAL_PORTFOLIO","candidate_id":"cip-nano-bio-handoff-service-004","proposal_index":4,"version":0,"title":"Standing Nano–Bio Handoff Qualification Service","problem":"A nanomaterials laboratory and a biological-assay facility repeatedly need to transform a characterized nanomaterial batch into an assay-admissible sample package. The transfer is feasible through full bilateral coordination, but each project reconstructs terminology, evidence, preparation instructions, custody records, contamination checks, dispersion requirements, and responsibility boundaries. Samples and reports therefore stall at the interface even when the material and proposed assay are already permitted. The recurring barrier is cross-disciplinary interpretation, trust, and handoff setup rather than nanomaterial synthesis or assay execution.","actors":["Nanomaterial synthesis scientist","Biological-assay scientist","Nanomaterial characterization specialist","Sample-preparation technician","Laboratory safety representative","Data and sample custodian","Nano–bio handoff specialist","Directors of the participating facilities"],"observable_state":"For each proposed handoff, the facilities can observe intake completeness, clarification exchanges, duplicated characterization, time awaiting interpretation, sample-custody discrepancies, routine versus exception classification, acceptance or rerouting, post-acceptance preparation deviations, unusable aliquots, downstream assay queue, specialist caseload, conflict disclosures, appeal use, and performance over successive completed handoffs.","consequence":"Repeated reconstruction consumes scientific and technician attention, delays otherwise permitted assays, and can introduce unrecorded differences in sample preparation. Pressure to move faster can instead produce incomplete evidence, inappropriate assay conditions, lost sample provenance, or informal gatekeeping. Increasing submissions without managing the interface can saturate both the handoff specialist and the receiving assay facility.","affected_objective":"Convert eligible nanomaterial batches and their records into traceable, assay-admissible sample packages with less repeated translation and coordination while preserving existing scientific, safety, custody, contamination, and assay-entry standards.","intervention":"Establish a standing, jointly governed nano–bio handoff qualification service. The service maintains relationships between participating facilities, a versioned semantic intake contract, and prevalidated handoff templates for bounded combinations of nanomaterial class, carrier condition, characterization evidence, and assay family. A synthesis team submits a physical aliquot and structured sample passport. The service checks completeness and compatibility, coordinates only the missing bridge evidence, confirms custody and handling instructions, and releases a qualified handoff package to the receiving facility. Explicit eligibility rules route routine cases through the reusable pathway; novel materials, ambiguous surface states, incompatible carriers, unusual hazards, or unresolved scientific questions go to full bilateral review. After each case, the service closes custody, records exceptions and downstream feedback, updates relationships and controlled documents, protects staff recovery time, and reauthorizes or suspends templates when governing conditions drift.","structural_mapping":[{"archetype_element":"Target transformation specification","domain_realization":"An eligible characterized nanomaterial batch, physical aliquot, and source records become a traceable package accepted for a specified assay under the receiving facility's unchanged entry criteria."},{"archetype_element":"Activation barrier model","domain_realization":"The hypothesized recurring burden is reconstruction of terminology, evidence meaning, handling assumptions, trust, custody, and responsibility at the materials-to-biology interface."},{"archetype_element":"Permitted pathway boundary","domain_realization":"The service covers only already authorized materials, handling conditions, facilities, and assay classes; it cannot certify biological safety, settle unresolved scientific feasibility, or waive protective review."},{"archetype_element":"Reusable facilitator","domain_realization":"The standing service reuses maintained relationships, translation knowledge, intake contracts, controlled templates, and specialist judgment across multiple independent handoffs."},{"archetype_element":"Facilitator–substrate interface","domain_realization":"A semantic contract specifies sample identity, batch provenance, composition, concentration basis, physical state, carrier, storage, handling, characterization methods, known limitations, custody, hazards, and requested assay context."},{"archetype_element":"Selectivity rule","domain_realization":"Only cases within a validated material-and-assay envelope use the routine path; ambiguity, unusual hazard, incompatible preparation, missing provenance, or novel scientific questions trigger clarification or full review."},{"archetype_element":"Facilitator regeneration cycle","domain_realization":"Case closeout restores the service through custody reconciliation, record completion, exception review, relationship maintenance, template refresh, staff recovery, coverage rotation, and reauthorization where needed."},{"archetype_element":"Turnover capacity model","domain_realization":"Capacity is measured as handoffs accepted without later interface-related correction per specialist team and unit time, including clarification, exception review, closeout, maintenance, recovery, and appeal work."},{"archetype_element":"Substrate access condition","domain_realization":"Any participating team may use published criteria and preparation support; incomplete or exceptional cases receive an alternate full-review route rather than discretionary exclusion."},{"archetype_element":"Saturation and interference monitor","domain_realization":"The service tracks queue depth, clarification load, exception fraction, specialist caseload, unresolved custody items, template age, staff availability, and receiving-assay capacity."},{"archetype_element":"Inhibitor or poison monitor","domain_realization":"Intake detects mislabeled aliquots, missing provenance, incompatible terminology, undisclosed treatment, contaminated containers, conflicting incentives, confidentiality restrictions, and ambiguous responsibility before routine qualification."},{"archetype_element":"Byproduct and side-pathway guardrail","domain_realization":"Guardrails track false qualification, unnecessary rejection, forced standardization, sample loss, undocumented preparation changes, confidentiality breaches, downstream assay disruption, and capture of access by the service."},{"archetype_element":"Equilibrium neutrality check","domain_realization":"The service may accelerate a handoff only when the sample could already be accepted through full bilateral review; it cannot make an incompatible sample, invalid assay, or unresolved hazard acceptable."},{"archetype_element":"Baseline and counterfactual measure","domain_realization":"Matched handoffs use either the existing project-by-project coordination route or the standing service while retaining identical assay-entry, custody, characterization, and safety criteria."},{"archetype_element":"Accountable catalyst steward","domain_realization":"A jointly appointed service lead owns access fairness, workload, template integrity, conflicts, records, incidents, succession, and suspension, while the receiving assay authority independently decides acceptance."}],"mechanism_mapping":[{"mechanism_slug":"reusable_broker_or_convener_service","role":"Maintains cross-disciplinary relationships, shared terminology, trust, and a governed route between synthesis and assay facilities, reusing that relational capital for successive handoffs.","counterfactual_removal":"Without the standing broker, each project pair would rebuild contacts, trust, translation, and responsibility boundaries from the beginning."},{"mechanism_slug":"interface_contract_design","role":"Publishes semantic input requirements, output guarantees, custody responsibilities, protected constraints, and versioned scope for routine handoffs.","counterfactual_removal":"Without the contract, formally complete records could remain scientifically ambiguous, and the service could widen its scope or reject cases inconsistently."},{"mechanism_slug":"prevalidated_transformation_template","role":"Carries forward an approved handoff structure for bounded material-and-assay combinations while exposing case-specific fields and preserving locked requirements.","counterfactual_removal":"Without a controlled template, the service would repeatedly reconstruct the same evidence and handling package, weakening turnover and consistency."},{"mechanism_slug":"fast_track_with_eligibility_rules","role":"Routes objectively routine, well-specified cases through the lower-friction qualification path while returning uncertainty and exceptions to full bilateral review.","counterfactual_removal":"Without explicit eligibility and rerouting, the service could become either an indiscriminate rubber stamp or a discretionary gatekeeper."},{"mechanism_slug":"embedded_specialist_review_lane","role":"Places a nano–bio handoff specialist at the recurring interface with caseload caps, escalation, conflict disclosure, refusal rights, backup coverage, and succession.","counterfactual_removal":"Without bounded specialist judgment, semantic mismatches would pass unnoticed or every case would still require an unstructured meeting among senior scientists."},{"mechanism_slug":"active_site_capacity_dashboard","role":"Shows queue depth, case state, clarification load, exception demand, staff availability, template validity, and receiving-assay capacity to support governed admission.","counterfactual_removal":"Without capacity visibility, more cases could be admitted into an exhausted service or an already saturated assay stage while high utilization is mistaken for health."},{"mechanism_slug":"turnover_and_selectivity_assay","role":"Measures successful handoffs per service cycle together with later corrections, false qualifications, unnecessary reroutes, sample losses, and access outcomes against the ordinary route.","counterfactual_removal":"Without multi-case turnover and whole-outcome measurement, easy-case selection or relaxed acceptance could be mislabeled as catalytic performance."},{"mechanism_slug":"catalyst_regeneration_protocol","role":"Restores readiness through closeout, record reconciliation, template refresh, retraining, relationship maintenance, rest, reauthorization, rotation, or retirement of degraded service elements.","counterfactual_removal":"Without regeneration, stale knowledge, unresolved cases, relationship decay, and staff exhaustion would accumulate while the service remained nominally available."},{"mechanism_slug":"small_safe_to_fail_probe","role":"Tests a bounded set of nonclinical handoffs with matched ordinary-route comparison, independent acceptance, appeals, and precommitted halt rules before institutional adoption.","counterfactual_removal":"Without a contained counterfactual probe, ordinary familiarity, selection of easy cases, or throughput pressure could be mistaken for reusable barrier reduction."}],"causal_chain":["A synthesis team has an authorized nanomaterial batch and a receiving assay facility with an applicable acceptance route, but the handoff repeatedly encounters translation, evidence, custody, and trust burdens.","A published semantic contract makes the batch, evidence, handling state, hazards, limitations, and requested assay context legible at the interface.","Eligibility checks separate routine cases from scientific, safety, provenance, or compatibility exceptions before the facilitator commits capacity.","The standing service reuses maintained relationships, controlled templates, and specialist interpretation to assemble only the bridge evidence and coordination needed for the case.","The receiving facility independently accepts, rejects, or escalates the qualified package under its unchanged substantive criteria.","Custody and downstream feedback reveal incomplete translation, preparation deviations, false qualification, unnecessary rerouting, or receiving-stage overload.","Closeout, relationship maintenance, controlled-document refresh, workload recovery, and reauthorization return the service to a ready state for another handoff.","Only repeated accepted handoffs without relaxed standards, proportional reconstruction effort, unfair exclusion, specialist exhaustion, or shifted downstream harm support continued operation."],"baseline":"Use the existing project-by-project bilateral handoff as the primary baseline. For a bounded set of comparable, already authorized material-and-assay combinations, keep sample quantity, characterization methods, safety review, custody requirements, assay-entry criteria, receiving staff, and downstream scheduling rules unchanged. Compare clarification exchanges, duplicated work, specialist effort, elapsed handoff time, acceptance and reroute decisions, custody discrepancies, sample loss, post-acceptance corrections, preparation deviations, downstream disruption, appeals, and total maintenance work. Report excluded and failed cases as well as accepted ones.","nearest_rivals":["A static universal sample-handoff checklist without a maintained service or regeneration cycle","Additional assay-facility staff performing the existing bilateral coordination process","A centralized facility that takes ownership of all characterization and sample preparation","A project-specific consultant engaged separately for each handoff","Mandating one material formulation or assay protocol to remove interface variation","A shared document repository without accountable interpretation or exception routing","Lowering assay-entry documentation or characterization requirements"],"remaining_contrastive_claim":"If supported, the narrow contrastive claim would be that a standing, accountable intermediary repeatedly lowers the translation, trust, evidence-reconstruction, and custody barrier for eligible nano–bio handoffs by reusing relationships and controlled pathway knowledge. The explanation requires selective access, measurable multi-case turnover, closeout and regeneration, independent acceptance, and bounded specialist capacity; it would not follow from a checklist, document repository, added bulk staffing, project-by-project consulting, forced uniformity, or weaker entry standards.","authority_safety":{"decision_authority":"The directors of the participating nanomaterials and assay facilities may jointly authorize the contained service probe. Each source custodian retains control of its samples and information, the receiving assay authority independently determines admissibility, and laboratory safety personnel retain authority over handling and containment.","authorized_first_step":"Pilot the service on a small, preselected set of nonclinical, already authorized handoffs spanning routine and deliberate exception cases. Preserve the ordinary bilateral route, use independent acceptance decisions, publish eligibility and appeal rules, cap specialist caseload, and pre-register comparison and halt criteria.","excluded_actions":["Human, animal, clinical, diagnostic, or environmental use","Certification that a nanomaterial is biologically safe or suitable beyond the receiving facility's established authority","Waiver of characterization, contamination, custody, confidentiality, safety, or assay-entry requirements","Unapproved alteration, dilution, relabeling, or disposal of submitted samples","Automatic qualification based only on document completeness","Exclusive control of facility access by the handoff service","Use of undisclosed project priority, affiliation, funding, or personal relationships as eligibility criteria","Expansion to new material or assay classes without revalidation and reauthorization","Increasing intake beyond specialist recovery or downstream assay capacity"],"halt_rollback":"Pause the affected handoff and route it to the ordinary bilateral process if sample identity or custody is uncertain, required evidence conflicts, contamination is suspected, the receiving authority disputes the template, a conflict of interest emerges, confidential information is mishandled, specialist workload exceeds the approved cap, or a qualified case produces an interface-related preparation error. Quarantine affected records and samples under existing custody rules, notify both facility authorities, preserve an appeal path, suspend implicated templates, and require cause review plus explicit reauthorization before reuse."},"negative_tests":{"strongest_counterevidence":"A controlled checklist or ordinary bilateral route produces the same handoff outcomes with comparable total effort, showing that a standing broker is unnecessary. The catalytic account is also contradicted if the service reconstructs evidence and relationships nearly from zero for every case, accepts only easy submissions, shifts work invisibly to source or receiving staff, or obtains faster acceptance by weakening the substantive standard.","problem_falsifier":"The inferred problem is falsified if observation shows that translation, trust, evidence reconstruction, and custody setup are not material sources of delay or failure—for example, if compatible packages already transfer cleanly and the binding constraints are assay capacity, unresolved biological feasibility, missing bulk sample, or an unapproved hazard.","intervention_falsifier":"The intervention is falsified if it cannot process successive eligible handoffs without proportional specialist effort, does not outperform baseline variation, increases false qualification or unnecessary rejection, loses sample or provenance, cannot recover after template or relationship drift, becomes an inequitable gatekeeper, exhausts staff, or merely enlarges the downstream assay queue.","risks":["The service becoming an unaccountable access gatekeeper","Conflicts of interest favoring particular facilities, projects, or materials","Human specialist overload, fatigue, dependency, or loss of independence","Knowledge concentration and succession failure","Exceptional materials being forced into routine templates","Stale templates carrying forward invalid assumptions","False reassurance from complete documentation despite scientific incompatibility","Unnecessary rejection of valid but unconventional cases","Undocumented sample preparation or custody changes","Confidentiality or intellectual-property disclosure","Hidden unpaid translation and maintenance labor","Downstream assay overload","Acceptance acceleration being confused with biological safety certification"]},"next_evidence_step":"Run one pre-registered pilot involving six already authorized handoffs: four expected to fit a bounded routine material-and-assay envelope and two selected to test exception detection and rerouting. Use matched ordinary-route cases or duplicate document-and-decision exercises where physical sample duplication is inappropriate. Measure intake completeness, clarification loops, duplicated characterization, specialist and participant effort, elapsed handoff time, acceptance and reroute accuracy, custody discrepancies, sample loss, post-acceptance corrections, preparation deviations, downstream load, appeals, closeout work, and staff recovery. Derive continuation, pause, and retirement thresholds from baseline variation, existing acceptance rules, and workload limits rather than assuming an effect size.","prior_art_status":"UNSEARCHED","diversity_from_prior_proposals":"Proposal 1 addressed a physicochemical nucleation barrier in gold nanocrystal seed synthesis using an immobilized nanoporous surface that contacts precursor aliquots and undergoes physical regeneration. This proposal performs no particle synthesis and uses a governed institutional broker to transform an existing batch and its evidence into an assay-admissible handoff. Proposal 2 addressed technical conversion of CAD designs into electron-beam lithography recipes through a software compiler, calibration state, and automated rule execution. This proposal instead addresses trust, disciplinary interpretation, custody, and responsibility across separate materials and biological facilities; human judgment, relationships, fair access, workload recovery, and independent acceptance are essential rather than exception support for software. Proposal 3 addressed mechanical deagglomeration of nanoparticle suspensions in a surface-acoustic-wave flow cell, with acoustic power, mass balance, heating, fouling, and particle integrity as the causal pathway. This proposal does not alter suspension structure or use an acoustic device; it coordinates evidence and physical sample custody through a reusable service. Each opportunity has different actors, substrate, output, barrier, facilitator, failure modes, authority, and adoption pathway, so this service can be adopted without implementing or modifying any of the first three proposals.","revision_record":{"parent_version":null,"progress_targets_addressed":["Initial complete proposal at index 4 with explicit differentiation from sealed proposals 1, 2, and 3."],"conceptual_changes":["Mapped catalytic reuse to a standing human and institutional nano–bio handoff service rather than to a material interface, software compiler, or acoustic device."],"operational_changes":["Defined semantic intake, objective eligibility, routine and exception paths, independent acceptance, custody safeguards, workload caps, appeals, closeout, relationship maintenance, reauthorization, and rollback."],"evidence_changes":["Specified a bounded nonclinical pilot containing routine and deliberate exception cases, an ordinary-route comparison, multi-actor effort accounting, and regeneration measures."],"claim_changes":["Limited the prospective claim to reusable reduction of cross-disciplinary handoff barriers under unchanged acceptance and safety standards; no novelty, prevalence, demand, or effect-size claim is made."]}}